Skip to content

Development of eye treatment method using amniotic membrane

Development of eye treatment method using amniotic membrane - Treatment using amniotic membrane

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000021435
Enrollment
20
Registered
2016-03-11
Start date
2016-03-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal scleral perforation, Infectious keratoconjunctivitis, Glaucoma

Interventions

None listed

Sponsors

Department of Ophthalmology and Visual Science, Tohoku University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: It is scheduled to undergo a Caesarean section at Tohoku University Hospital,who was to give a consent to this study.

Exclusion criteria

Exclusion criteria: Minor Adult who does not have sufficient judgment Unconscious adult person Adult's attention must be paid to the disease name

Design outcomes

Primary

MeasureTime frame
Amniotic menbrane is expected utility as instead of the corneal donor

Countries

Japan

Contacts

Public ContactShunji Yokokura

Tohoku University Graduate School of Medicine Department of Ophthalmology and Visual Science

yokokura@oph.med.tohoku.ac.jp022-717-7294

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026